Abstract
SARS-CoV-2 infection is a global public health problem, causing significant morbidity and mortality. Evidence shows that obesity is a recognized risk factor for hospitalization, admission to critical care units, and the development of serious complications from COVID-19. This review analyzes the available epidemiological evidence that relates obesity to a higher risk of severity and mortality from COVID-19, examining the possible pathophysiological mechanisms that explain this phenomenon on a cellular and molecular level.
Funder
Vicerrectoría de Investigación y Postgrado, Universidad Católica de Temuco, Chile.
Subject
Health Information Management,Health Informatics,Health Policy,Leadership and Management
Reference63 articles.
1. Mapa de COVID-19—Johns Hopkins Coronavirus Resource Centerhttps://coronavirus.jhu.edu/map.html
2. SARS-CoV-2 y Pandemia de Síndrome Respiratorio Agudo (COVID-19);Ruiz-Bravo;Ars Pharm.,2020
3. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
4. Comorbilidades y gravedad clínica de la COVID-19: Revisión sistemática y meta-análisis;Plasencia-Urizarri;Rev. Habanera Cienc. Médicas,2020
5. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献